Emmace will have a strong presence during the upcoming DDL2018 conference. Please drop by and have a chat with our advisors and specialists. Emmace Consulting is a Bronze Sponsor (booth 314) at Drug Delivery to the Lungs 2018 in Edinburgh 12th-14th December.
Emmace Consulting söker en Analytisk Kemist – Karakterisering av Inhalerade Läkemedel Är du en självständig och driven kemist med stor vilja att generera analysdata till vår kunders olika projekt? Då har Emmace en tjänst för dig. Arbetet innebär att planera och utföra kemiska analyser, sammanställa dessa samt att redovisa utfallet gentemot kund. Vi lägger vikt på att vår nya medarbetare är ansvarsfull, kan ta egna initiativ, är ambitiös, självständig och resultatorienterad. Du är analytisk i ditt arbetssätt, och harkort startsträcka vad gäller experimentellt arbete. Läs mer om tjänsten
Per Bäckman, Senior Inhalation Consultant, now in our team. #amazingstaff ;-) Read more about Emmace Team
Emmace Consulting is attending RDD 2018 in Arizona as a technology exhibitor. Both Bo Olsson and Mårten Svensson will be happy to discuss how Emmace Consulting can help you develop inhaled products. Two posters are also presented. Please drop by and have a chat with us. Bo Olsson is also presenting the Mimetikos Preludium on the podium (Session 6). Don't miss the opportunity to book a personal F2F demonstration of the unique software. Read more about the capabilities of Emmace Consulting and Mimetikos Preludium™ Software.
During the upcoming DDL2017 conference, Dr. Bo Olsson, Senior Advisor at Emmace Consulting, will be happy to demonstrate the Mimetikos Preludium application for anyone interested. Book a F2F meeting with Bo by contacting him at firstname.lastname@example.org. Emmace Consulting is a Bronze Sponsor at Drug Delivery to the Lungs 2017 in Edinburgh 6th-8th December. Come and visit us at booth 314 in The Lennox Suite. Mimetikos Preludium™ software is a modeling package for estimating regional deposition of inhaled aerosols in man. The package is particularly focused on pharmaceutical aerosols but is equally applicable to environmental aerosols. Read more about Mimetikos Preludium™ Software
Emmace Consulting has, in collaboration with S5 Consulting and Jolyon Mitchell Inhaler Consulting Services Inc, jointly published an analytical test approach that is more in-vivo like than the existing pharmacopeia methods. Don’t hesitate to contact the authors for more information.
Joint Research Agreement between Emmace Consulting AB, Mylan Pharma UK LtD and the University of Cyprus
In May 2017, the University of Cyprus (Cyprus), Mylan Pharma UK Ltd (UK), and Emmace Consulting AB entered into a joint research agreement with the aim of developing a state-of-the-art scientific methodology to study upper airway deposition of inhaled medicines. The collaboration will effectively combine the key competencies of the computational Sciences Laboratory at UCY (UCy-CompSci) and their High Performance Computing (HPC) system, the skilled aerosol characterization laboratories at Emmace Consulting AB and the respiratory product development expertise of Mylan Pharma UK Ltd. This collaboration also marks an important milestone for the European Union COST Action MP1404 - “SimInhale” which is coordinated by UCY-CompSci. First results are planned to be reported in the scientific literature in early 2018.
Emmace Consulting is proud to present the release of Mimetikos Preludium™, a software for estimating regional deposition of inhaled aerosols in man. Mimetikos Preludium™ software is a modeling package for estimating regional deposition of inhaled aerosols in man. The package is particularly focused on pharmaceutical aerosols but is equally applicable to environmental aerosols. It is primarily a research tool but due to its near instant response, the graphical abilities and the in-depth details it is also superb for education and ‘what-if’ analyses. Read more about Mimetikos Preludium™
Emmace Consulting AB offers dissolution testing of medicated chewing gums as an analytical service to clients on a CRO basis. The testing is performed according to Eur. Pharmacopoeia 2.9.25, using Apparatus B. Read more